AbGONE breakthrough pill targets abdominal fat and water
Biotech Research announces a new pill named AbGONE that claims to reduce abdominal fat and water. Developed from Yale, Pittsburgh, UCLA, and California research, it targets both outer and intestinal fat with CLA and other nutriceuticals, offering a 30 day supply and direct ordering options.
MENTIONED IN THIS ARTICLE
John Whitehead
Biotech Research
Yale
Pittsburgh
Ucla
California
Rehan Jalali
Jalali
Yale University
University of California
San Francisco
University of Naples
Italy
Cal State University
U.S
Uppsala University
Sweden
Unclear Text From Medical Publication
Fragmentary notes reference FDA statements about diagnosis fitness goals and exercise. The garbled text mentions diet and endorsement but lacks coherent details or names to anchor a complete report.
MENTIONED IN THIS ARTICLE
FDA
Also Mentioned on This Page
CVS
Happy Harry’s
Rite Aid
Medic Drug
Longs Drugs
Kmart
Walgreens
Abgone
Newsweek
Muscle & Fitness
Oxygen
Men’s Fitness
Muscle Media
Wmacol
Search
Matic Med
Sity
Srensemeeneas Oer
Med
Aive
If Sport
Ta Harhal Medicin
Rnishers
Itute Or Im
Ig S
Harry
Druga
VISA
MasterCard Am
Optimal
Discover
Novus
Biotech Research Dept
Whipple Ave
N.W
Canton